ABC.L Regulatory News (ABC)

ABCAM PLC

("Abcam" or "the Company")

PDMR dealing

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of innovative protein research tools, was today notified that on 25 April 2014, Ed Ralph, a PDMR of the Company, sold 10,000 ordinary shares of 0.2 pence each in the Company (Ordinary Shares), and his wife, Victoria Ralph also sold 10,000 Ordinary Shares, both trades at a price of 390.25p per Ordinary Share.

Following these transactions, Dr Ralph's total beneficial interest in the Company (including that of his spouse) is 340,352 Ordinary Shares, representing approximately 0.17 per cent of the current issued share capital of the Company. 

For further information please contact:

Notes for editors:

About Abcam plc

Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level to improve the understanding of health and disease.

Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 130,000 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported by detailed, up-to-date and unbiased data on our website.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).

To find out more, please visit www.abcam.com